Sonnet BioTherapeutics SONN released its Q4 earnings on Tuesday, December 17, 2024 at 08:50 AM.
Here's what's important from the earnings announcement.
Earnings
Sonnet BioTherapeutics beat estimated earnings by 27.0%, reporting an EPS of $-3.67 versus an estimate of $-5.04.
Revenue was down $37 thousand from the same period last year.
Performance in Previous Earnings
The company beat on EPS by $0.48 in the last quarter, resulting in a 13.0% increase share price change the following day.
Here's a look at Sonnet BioTherapeutics's past performance:
| Quarter | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| EPS Estimate | -6.08 | 1.04 | -7.20 | -7.20 |
| EPS Actual | -5.60 | 0.56 | -2.48 | -6.24 |
| Revenue Estimate | 30K | 10K | 20K | 20K |
| Revenue Actual | 0 | 0 | 18K | 37K |
Listen to the earnings announcement yourself by clicking here.
To track all earnings releases for Sonnet BioTherapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.